Clinical trial
Long-Term Lamivudine Therapy for Chronic Hepatitis B
NCT00120354 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Lamivudine Therapy for Chronic Hepatitis B
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 11, 2005
- Completion date
- March 31, 2007
- Enrollment
- 50
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.